Labyrinth anesthesia - A forgotten but practical treatment option in Ménière's disease

ORL

Volumn 65, Issue 2, 2003, Pages 84-90

  Adunka, Oliver ^a   Moustaklis, Elena ^a   Weber, Alexander ^b   May, Angelika ^a   Von Ilberg, Christoph ^a   Gstoettner, Wolfgang ^a   Kierner, Antonius C ^c  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Eye Hospital   (Germany)

^c University Clinic Vienna   (Austria)

Author keywords

Hearing impairment; Labyrinth anesthesia; Lidocaine; M ni re's disease; Vertigo

Indexed keywords

ADENINE DERIVATIVE; FURFURYL ADENINE; LIDOCAINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANESTHESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARDRUM; EVALUATION; FEMALE; HEARING LOSS; HUMAN; LABYRINTH ANESTHESIA; LOCAL ANESTHESIA; MALE; MENIERE DISEASE; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; TINNITUS; TREATMENT OUTCOME; VERTIGO;

ADENINE; ADULT; AGED; AGED, 80 AND OVER; ANESTHETICS, LOCAL; EAR, INNER; FEMALE; HEARING LOSS; HUMANS; INSTILLATION, DRUG; KINETIN; LIDOCAINE; MALE; MEDICAL RECORDS; MENIERE'S DISEASE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TINNITUS; TREATMENT OUTCOME; VERTIGO;

EID: 0037631775     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070771     Document Type: Article

References (29)

1. Charcot JM: De la maladie de Ménière. Prog Med Paris 1874;2:49-51.
2. House WF: Surgical exposure of the internal auditory canal and its contents through the middle cranial fossa. Laryngoscope 1961;71:1363.
3. Glasscock ME: Vestibular nerve section. Arch Otolaryngol Head Neck Surg 1973;97:112-114.
4. Fisch U: Vestibular and cochlear neurectomy. Trans Am Acad Ophthalmol Otolaryngol 1977;78:252-254.
5. Grant IL, Welling DB: The treatment of hearing loss in Ménière's disease. Otolaryngol Clin North Am 1997;30:1123-1144.
6. Silverstein H, Norrell H: Retrolabyrinthine surgery: A direct approach to the cerebellopontine angle. Otolaryngol Head Neck Surg 1980;88:462-469.
7. Hitselberger WE, Pulec JL: Trigeminal nerve (posterior root) retrolabyrinthine selective section. Operative procedure for intractable pain. Arch Otolaryngol 1972;96:412-415.
8. Thomsen J, Tos M: Surgery of acoustic neuromas. Preliminary experience with a translabyrinthine approach. Acta Neurol Scand 1977;56:277-290.
9. Magnan J, Bremond G, Chays A, Gignac D, Florence A: Vestibular neurotomy by retrosigmoid approach: Technique, indications and results. Am J Otol 1991;12:101-104.
10. Thomsen J, Berner B, Tos M: Vestibular neurectomy. Auris Nasus Larynx 2000;27:297-301.
11. Portmann G: Vertigo, surgical treatment of opening of the saccus endolymphaticus. Arch Otolaryngol Head Neck Surg 1927;6:309.
12. Schuknecht HF: Ablation therapy for the relief of Ménière's disease. Laryngoscope 1956;66:859-870.
13. Wilson W, Schuknecht HF: Update on the use of streptomycin therapy for Ménière's disease. Am J Otol 1980;2:108-111.
14. Nedzelski JM, Chiong CM, Fradet G, Schessel DA, Bryce GE, Pfleiderer AG: Intratympanic gentamicin instillation as treatment of unilateral Ménière's disease: Update of an ongoing study. Am J Otol 1993;14:278-282.
15. Bárány B: Die Beeinflussung des Ohrensausens durch intravenös injizierte Lokalanästhetica. Acta Otolaryngol 1935;23:201-207.
16. Lempert J: Tympanosympathectomy, a surgical technic for releaf of tinnitus aurium. Arch Otolaryngol 1946;43:199-204.
17. Kroath F: Transtympanale Injektion zur Behandlung des Ménière'schen Syndroms. Z Laryngol 1960;34:190-196.
18. Rahm WE: The effect of anesthetics upon the ear. Ann ORL 1962;79:116-122.
19. Gejrot T: Intravenous xylocaine in the treatment of attacks of Ménière's disease. Acta Otolaryngol 1963;188(suppl):190-198.
20. Ristow W: Der Einfluss der Schleimhautanästhetika auf das Vestibularsystem und seine therapeutische Wirkung; in Loebell H, Jakobi H (eds): Zwanglose Schriftenreihe. Leipzig, J.A. Barth, 1964, Heft 12.
21. Ristow W: Zur Behandlung der Ménière-Krankheit mittels temporärer Labyrinthanästhesie. Z Laryngol Rhinol 1968;47:442-448.
22. Fradis M, Podoshin L, Ben-David J, Reiner B: Treatment of Ménière's disease by intratympanic injection with lidocaine. Arch Otolaryngol 1985;111:491-493.
23. Sakata E, Kitago Y, Murata Y, Teramoto K: Behandlung der Ménièreschen Krankheit. Paukenhöhleninfusion von Lidocain- und Steroidlösung. Auris Nasus Larynx 1986;13:79-89.
24. Itoh A, Sakata E: Treatment of vestibular disorders. Acta Otolaryngol 1991;481:617-623.
25. Anon. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995; 113:181-185.
26. Lindquist NG, Ullberg S: The melanin affinity of chloroquine and chlorpromazine studied by whole body autoradiography. Acta Pharmacol Toxicol 1972;2(suppl 2):1-32.
27. 14C-lidocaine in the inner ear. Acta Otolaryngol 1976;82:297-300.
28. Lyttkens L, Larsson B, Göller H, Englesson S, Stahle J: Melanin capacity to accumulate drugs in the internal ear. A study on lidocaine, bupivacaine and chlorpromazine. Acta Otolaryngol 1979;88:61-73.
29. Dencker L, Lindquist NG: Distribution of labeled chloroquine in the inner ear. Arch Otolaryngol 1975;101:185-188.